INSM
InsmedDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
INSM vs peer average
31/100
INSM vs. peer average (D vs. C)
Grade spread
A 1 · B 4 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ALNY is the first available peer comparator.
Rare-disease/biotech with commercialization experience — useful for development-to-revenue transition risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
INSM
Insmed
ALNY
Alnylam
Grade
D
C
Momentum
4
19
Value
41
58
Sentiment
100
89
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs ALNY
INSM / ALNY
Grade Position
Below peers
INSM vs. peer average (D vs. C)
31/100
Momentum
4
ALNYValue
41
ALNYSentiment
100
INSMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs INSM
ALNY is the first peer returned for this comparison set.

